Stem Cell Research Enhancement Act

From the American Diabetes Association - April 2007

The use of stem cell research in biomedical research, provided such use is consistent with federal guidelines relating to the bioethics for their use is being supported by many institutions such as The American Diabetes Association. Scientists from across the United States and throughout the world – including those at ADA – believe that stem cell research, especially embryonic stem cell research, holds great promise in the search for a cure and better treatments for diabetes.

Stem cell research allows scientists to better explore how to control and direct stem cells so they can grow into other cells, such as insulin-producing beta cells found in the pancreas. Creating new beta cells could mean a cure for type 1 diabetes as they would serve as a replenishing source of cells for islet cell transplantation. They could also provide a powerful tool for controlling type 2 diabetes.

The Association strongly supports H.R.3/S.5, the "Stem Cell Research Enhancement Act," which would expand federal funding for embryonic stem cell research, while keeping President Bush's ethical framework from his 2001 policy. In the last session of Congress, both the House of Representatives and Senate passed the bill with bipartisan support, but were unable to override President Bush's veto.

Fortunately, the bill has been reintroduced and it has already passed the U.S. House of Representatives. The Senate is currently considering this bill and a vote is expected during the week of April 9. ADA will continue to fight to expand the federal commitment to stem cell research.

Click here for more information